Project Title: Phase II Experimental hut and Phase III community study for Evaluation of SumiShield 50WG for Indoor Residual Spraying (IRS) in Tanzania
Project Description: There is a long history of using indoor residual spraying (IRS) for malaria control and it has proved very effective in Tanzania and other countries. However, the usefulness of IRS is under threat due to increase mosquito resistance to all 4 classes of insecticides. There has been a need for a new mode of Action (MOA) product for many years and nothing has been introduced for more than 30 years. Insecticide resistance is now widespread... There is a long history of using indoor residual spraying (IRS) for malaria control and it has proved very effective in Tanzania and other countries. However, the usefulness of IRS is under threat due to increase mosquito resistance to all 4 classes of insecticides. There has been a need for a new mode of Action (MOA) product for many years and nothing has been introduced for more than 30 years. Insecticide resistance is now widespread in Tanzania and is increasing in many parts of the world so there is a great need for an insecticide with a new MOA and one that can be used in resistance management and rotational programmes We propose to evaluate the neonicotinoid clothianidin as an insecticide for IRS in Tanzania. This insecticide has good potential for the use of IRS against malaria vectors. Laboratory and field trials have shown great promise resulting in Sumimoto submitting the product Sumishield 50WG to the WHO Pesticide Evaluation Scheme (WHOPES) for evaluation and recommendation. By conducting the study in Tanzania we will obtain evidence needed by National Malaria Control Programme (NMCP) for their objective to improve integrated vector management to consider new innovations especially those that address the emerging threat of insecticide resistance and preserving the effectiveness of modern malaria vector control.
Principal Investigator : Sarah Moore
Department Name : EHES
Time frame: (2016-06-01) - (2017-12-31)
World Health Organization (WHO) (Normal)
External Collaborating Partners
None added yet.